What question did this study set out to answer?

Assess the challenges providers face when deciding sports participation for pediatric athletes with hypertrophic cardiomyopathy.

March 28, 2026Open Access

Adolescent Athlete With PRKAG2 Hypertrophic Cardiomyopathy

Key Result

Pediatric athletes with PRKAG2 hypertrophic cardiomyopathy present challenging clinical decisions for providers regarding competitive sports participation.

Key Points

Assess the challenges providers face when deciding sports participation for pediatric athletes with hypertrophic cardiomyopathy.
Case analysis of a pediatric athlete diagnosed with PRKAG2-related hypertrophic cardiomyopathy.
Evaluation of sports participation criteria.
Review of treatment options and guidelines for athletes.
Providers face complex decisions regarding safe competitive participation.
Variation in treatment approaches can significantly affect athlete's eligibility for sports.

Structured PICO

Population

Adolescent athlete with PRKAG2 hypertrophic cardiomyopathy

Highlights the challenging decisions providers face regarding competitive sports participation for pediatric athletes with hypertrophic cardiomyopathy.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

Providers treating pediatric athletes with hypertrophic cardiomyopathy (HCM) face challenging decisions for competitive sports participation.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Russell et al. (Sun,) reported a other. Pediatric athletes with PRKAG2 hypertrophic cardiomyopathy present challenging clinical decisions for providers regarding competitive sports participation.

synapsesocial.com/papers/69c76fff8bbfbc51511e05e3 https://doi.org/https://doi.org/10.1016/j.jaccas.2026.107154

Bookmark

View Full Paper